FDA Inspection 1300828 — Baystate Medical Center IRB

Baystate Medical Center IRB — FEI 1283379

The FDA completed an inspection of Baystate Medical Center IRB on February 2, 2026 in Springfield, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 2, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Springfield, MA (United States)

Additional Details

IRB

Citations

IDCFRDescription
731821 CFR 56.115(a)(2)Minutes of IRB meetings